Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

OrthoAccel Receives Program Approval for Continuing Education (PACE) by Academy of General Dentistry

OrthoAccel Technologies,Inc.
Posted on: 17 Sep 16

PR Newswire

HOUSTON, Aug. 31, 2016

HOUSTON, Aug. 31, 2016 /PRNewswire/ -- The leader in accelerated orthodontics, OrthoAccel® Technologies, Inc., today announced it has received a Program Approval for Continuing Education (PACE) designation by the Academy of General Dentistry (AGD).

Photo - http://photos.prnewswire.com/prnh/20160831/403047

According to the AGD, PACE was established to create, improve and promote quality dental continuing education (CE) and to assist professionals with identifying appropriate CE opportunities. As an approved PACE provider, OrthoAccel has demonstrated its commitment to creating and delivering continuing education programs that support the rigorous standards established by PACE. These standards ensure that premier educational organizations from across the world follow generally accepted best practices in offering CE programs.

"Seeking and receiving this prestigious AGD PACE designation further demonstrates OrthoAccel's commitment to delivering scientifically sound continuing dental education. The goal is to enhance the knowledge, skill and ability of individual participants so that they can continue providing the highest quality of service to the public and the profession," said Michael K. Lowe, president and CEO of OrthoAccel, the creator and manufacturer of clinically proven AcceleDent®, the first and only FDA-cleared vibratory orthodontic device that speeds up treatment by as much as 50 percent and relieves discomfort associated with treatment.

OrthoAccel will now provide CE hours directly to orthodontists, staff members and other professionals who attend OrthoAccel educational programs including webinars, live-instructional events, case study presentations, online independent study courses and other learning opportunities. Presenters will also receive CE hours for delivering these types of educational programming through OrthoAccel's PACE providership.

For information about OrthoAccel's continuing education opportunities, visit acceledent.com/orthodontists.

About OrthoAccel® Technologies, Inc.

OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the creation, manufacturing, marketing and sales of innovative solutions that enhance dental care and orthodontic treatment. Among the company's innovations is AcceleDent®, an FDA-cleared, Class II medical device that is clinically proven to speed up orthodontic treatment by as much as 50 percent and reduce discomfort associated with orthodontic treatment when used in conjunction with braces or aligners. OrthoAccel, the Leader in Accelerated Orthodontics, has received positive feedback from patients and leading orthodontists from around the world who recommend the award-winning AcceleDent as the fast, safe and gentle solution to accelerate orthodontic treatment. Ranked on Deloitte's 2015 Technology Fast 500 as one of the fastest growing companies in North America, OrthoAccel is based in Houston, Texas and maintains a global presence through its EMEA office in Essen, Germany. To learn more about OrthoAccel's focus on improving the journey to healthy, beautiful smiles, visit AcceleDent.com.

OthoAccel® Technologies, Inc. is designated as an approved PACE program provider by the Academy of General Dentistry. The formal continuing education programs of this program provider are accepted by AGD for fellowship, mastership and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from 9/1/2016 to 8/31/2017. Provider ID# 371902.


PR Newswire
www.prnewswire.com

Last updated on: 17/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.